person · Reporting owner

Groetelaars John P

Disclosed activity across 5 companies

Tapewire entity: 50839
SEC CIK: 0001580664

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BECTON DICKINSON & COBDX · Entity 2498	EVP	January 02, 2018	January 04, 2018
DENTSPLY SIRONA Inc.XRAY · Entity 4448	Director · Interim Chief Executive Office	April 14, 2023	April 18, 2023
Medtronic plcMDT · Entity 2888	Director	April 27, 2026	April 29, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BECTON DICKINSON & CO

Report date January 02, 2018 · Filed January 04, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	42,508	Reported balance After 2018-01-02 transaction · row 1 1 source row Row 1 · 2018-01-02 · Grant · Acquired 6,157 · Balance 42,508 F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $217.84 · Expires 2028-01-02	Direct	20,045	Reported balance After 2018-01-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-01-02 · Grant · Acquired 20,045 · Balance 20,045 F2: The stock appreciation rights vest in four annual installments beginning January 2, 2019.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: The stock appreciation rights vest in four annual installments beginning January 2, 2019.

DENTSPLY SIRONA Inc.

Report date April 14, 2023 · Filed April 18, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	148,173.732	Reported balance After 2023-04-14 transaction · row 1 1 source row Row 1 · 2023-04-14 · Grant · Acquired 16.892 · Balance 148,173.732 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Filing footnotes · ownership attribution and instrument terms

F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Medtronic plc

Report date April 27, 2026 · Filed April 29, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	1,444	Reported balance After 2026-04-27 transaction · row 1 1 source row Row 1 · 2026-04-27 · Grant · Acquired 1,444 · Balance 1,444 F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

BARD C R INC /NJ/

Report date December 29, 2017 · Filed January 03, 2018

Section 16 reporting ended · disclosed 2018-01-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	33,178.929	Reported balance After 2017-12-29 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2017-12-29 · Grant · Acquired 14,216 · Balance 33,178.929 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2: Includes 14,216 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
Common StockSEC Table I · non-derivative	Direct	39,447.929	Reported balance After 2017-12-29 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2017-12-29 · Grant · Acquired 6,269 · Balance 39,447.929 F3: Includes 6,269 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.
Common StockSEC Table I · non-derivative	Direct	39,447	Reported balance After 2017-12-29 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2017-12-29 · Disposition to issuer · Disposed 0.929 · Balance 39,447 F4: Includes 0.929 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
Common StockSEC Table I · non-derivative	Direct	30,894	Reported balance After 2017-12-29 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2017-12-29 · Disposition to issuer · Disposed 8,553 · Balance 30,894 F5: Includes 8,553 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.
Common StockSEC Table I · non-derivative	Direct	16,678	Reported balance After 2017-12-29 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2017-12-29 · Disposition to issuer · Disposed 14,216 · Balance 16,678 F2: Includes 14,216 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-12-29 transaction · row 6 Account or security details depend on footnotes; rows are not merged. 1 source row Row 6 · 2017-12-29 · Disposition to issuer · Disposed 16,678 · Balance 0 F6: Includes 16,678 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $186.43 · Expires 2025-12-09	Direct	0	Reported balance After 2017-12-29 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-12-29 · Disposition to issuer · Disposed 15,806 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.87 · Expires 2024-12-10	Direct	0	Reported balance After 2017-12-29 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-12-29 · Disposition to issuer · Disposed 13,186 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.37 · Expires 2023-12-11	Direct	0	Reported balance After 2017-12-29 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-12-29 · Disposition to issuer · Disposed 4,161 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $219.56 · Expires 2026-12-14	Direct	0	Reported balance After 2017-12-29 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-12-29 · Disposition to issuer · Disposed 13,581 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger.

F2: Includes 14,216 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.

F3: Includes 6,269 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.

F4: Includes 0.929 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.

F5: Includes 8,553 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.

F6: Includes 16,678 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.

F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.

Hill-Rom Holdings, Inc.

Report date December 13, 2021 · Filed December 15, 2021

Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2021-12-13 transaction · row 1 1 source row Row 1 · 2021-12-13 · Disposition to issuer · Disposed 34,870 · Balance 0 F1: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.08 · Expires 2028-05-14	Direct	Reported balance After 2021-12-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-12-13 · Disposition to issuer · Disposed 39,962 · Balance 0 F2: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on May 14, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.08 · Expires 2028-05-14	Direct	Reported balance After 2021-12-13 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-12-13 · Disposition to issuer · Disposed 51,400 · Balance 0 F3: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on May 14, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $96.96 · Expires 2028-11-07	Direct	Reported balance After 2021-12-13 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-12-13 · Disposition to issuer · Disposed 42,314 · Balance 0 F4: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 7, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $103.11 · Expires 2029-11-06	Direct	Reported balance After 2021-12-13 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-12-13 · Disposition to issuer · Disposed 51,127 · Balance 0 F5: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $94.14 · Expires 2030-11-11	Direct	Reported balance After 2021-12-13 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-12-13 · Disposition to issuer · Disposed 59,783 · Balance 0 F6: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
Restricted Stock Units (11/06/2019)SEC Table II · derivative / convertible security	Direct	Reported balance After 2021-12-13 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-12-13 · Disposition to issuer · Disposed 24,594 · Balance 0 F7: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F8: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level.
Restricted Stock Units (11/06/2019)SEC Table II · derivative / convertible security	Direct	Reported balance After 2021-12-13 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-12-13 · Disposition to issuer · Disposed 4,128 · Balance 0 F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F11: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.
Restricted Stock Units (11/11/2020)SEC Table II · derivative / convertible security	Direct	Reported balance After 2021-12-13 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-12-13 · Disposition to issuer · Disposed 30,304 · Balance 0 F7: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F9: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level.
Restricted Stock Units (11/11/2020)SEC Table II · derivative / convertible security	Direct	Reported balance After 2021-12-13 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-12-13 · Disposition to issuer · Disposed 10,083 · Balance 0 F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F12: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.
Restricted Stock Units (11/10/2021)SEC Table II · derivative / convertible security	Direct	Reported balance After 2021-12-13 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-12-13 · Disposition to issuer · Disposed 46,502 · Balance 0 F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F13: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock.

F2: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on May 14, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

F3: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on May 14, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

F4: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 7, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

F5: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

F6: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

F7: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.

F8: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level.

F9: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level.

F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.

F11: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.

F12: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.

F13: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 07, 2018 Filed Nov 9, 2018 16:16 UTC	Hill-Rom Holdings, Inc. HRC · Entity 132395	GrantEmployee Stock Option (11/7/2018) · Derivative	42,314	$0.00 Strike: $96.96	$0.00	Disclosure SEC source: 0000047518-18-000108 · wf-form4_154179815605762.xml · derivative · entry 2 Groetelaars John P · CIK 0001580664 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,314 Underlying: Common Stock · 42,314 shares Expires 2028-11-07 F1 · derivative.exercise_date: Stock options vest 25% on each of November 7, 2019, 2020, 2021 and 2022. Read SEC document
May 14, 2018 Filed May 16, 2018 16:06 UTC	Hill-Rom Holdings, Inc. HRC · Entity 132395	GrantEmployee Stock Option Award (05/14/2018) 3yr · Derivative	51,400	$0.00 Strike: $89.08	$0.00	Disclosure SEC source: 0000047518-18-000053 · wf-form4_152650116606386.xml · derivative · entry 4 Groetelaars John P · CIK 0001580664 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,400 Underlying: Common Stock · 51,400 shares Expires 2028-05-14 F4 · derivative.exercise_date: Options vest 34% on May 14, 2019 and 33% on May 14, 2020 and 2021. Read SEC document
May 14, 2018 Filed May 16, 2018 16:06 UTC	Hill-Rom Holdings, Inc. HRC · Entity 132395	GrantEmployee Stock Option Award (05/14/2018) 4yr · Derivative	39,962	$0.00 Strike: $89.08	$0.00	Disclosure SEC source: 0000047518-18-000053 · wf-form4_152650116606386.xml · derivative · entry 3 Groetelaars John P · CIK 0001580664 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,962 Underlying: Common Stock · 39,962 shares Expires 2028-05-14 F3 · derivative.exercise_date: Options vest 25% on each May 14, 2019, 2020, 2021 and 2022. Read SEC document
May 14, 2018 Filed May 16, 2018 16:06 UTC	Hill-Rom Holdings, Inc. HRC · Entity 132395	GrantRestricted Stock Units (05/14/2018) · Derivative	11,505	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000047518-18-000053 · wf-form4_152650116606386.xml · derivative · entry 2 Groetelaars John P · CIK 0001580664 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,505 Underlying: Common Stock · 11,505 shares Expires 2021-05-15 F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted stock units will automatically be converted into shares of common stock on the date indicated unless a previous deferral election is made. Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F2 · derivative.expiration_date: Restricted stock units will automatically be converted into shares of common stock on the date indicated unless a previous deferral election is made. Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document
January 02, 2018 Filed Jan 4, 2018 17:21 UTC	BECTON DICKINSON & CO BDX · Entity 2498	GrantStock Appreciation Rights · Derivative	20,045	$0.00 Strike: $217.84	$0.00	Disclosure SEC source: 0001543407-18-000008 · edgar.xml · derivative · entry 2 Groetelaars John P · CIK 0001580664 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,045 Underlying: Common Stock · 20,045 shares Expires 2028-01-02 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning January 2, 2019. Read SEC document
January 02, 2018 Filed Jan 4, 2018 17:21 UTC	BECTON DICKINSON & CO BDX · Entity 2498	GrantCommon Stock	6,157	$0.00	$0.00	Disclosure SEC source: 0001543407-18-000008 · edgar.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,508 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	13,581	Not disclosed Strike: $219.56	Not disclosed	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · derivative · entry 10 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,581 shares Expires 2026-12-14 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	4,161	Not disclosed Strike: $136.37	Not disclosed	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · derivative · entry 9 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,161 shares Expires 2023-12-11 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	13,186	Not disclosed Strike: $168.87	Not disclosed	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · derivative · entry 8 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,186 shares Expires 2024-12-10 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	15,806	Not disclosed Strike: $186.43	Not disclosed	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · derivative · entry 7 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,806 shares Expires 2025-12-09 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	16,678	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · nonDerivative · entry 6 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F6 · price: Includes 16,678 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	14,216	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · nonDerivative · entry 5 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,678 F2 · price: Includes 14,216 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	8,553	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · nonDerivative · entry 4 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,894 F5 · price: Includes 8,553 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	0.929	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · nonDerivative · entry 3 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,447 F4 · price: Includes 0.929 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	6,269	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · nonDerivative · entry 2 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,447.929 F3 · price: Includes 6,269 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	14,216	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000503 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,178.929 F1 · security: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2 · price: Includes 14,216 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionOption (Right to Buy) · Derivative	2,597	$0.00 Strike: $84.58	$0.00	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · derivative · entry 7 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,597 shares Expires 2021-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F4 · derivative.exercise_date: Options fully vested and are currently exercisable. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionOption (Right to Buy) · Derivative	8,608	$0.00 Strike: $97.69	$0.00	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · derivative · entry 6 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,608 shares Expires 2022-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F4 · derivative.exercise_date: Options fully vested and are currently exercisable. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionOption (Right to Buy) · Derivative	12,482	$0.00 Strike: $136.37	$0.00	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · derivative · entry 5 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,161 Underlying: Common Stock · 12,482 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F3 · derivative.exercise_date: Of this option grant 12,482 options vested and the remaining options vest on December 11, 2017. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	23,687	$318.73	$7,549,833.31	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · nonDerivative · entry 4 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,962.929 F1 · price: Represents the weighted average sales price for price increments ranging from $318.52 to $318.91. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionCommon Stock	2,597	$84.58	$219,641.28	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · nonDerivative · entry 3 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,649.929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionCommon Stock	8,608	$97.69	$840,872.48	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · nonDerivative · entry 2 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,052.929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 10, 2017 Filed Aug 11, 2017 12:19 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionCommon Stock	12,482	$136.37	$1,702,170.34	Disclosure SEC source: 0001225208-17-013770 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,444.929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 14, 2017 Filed Feb 15, 2017 16:58 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	732	$240.49	$176,039.70	Disclosure SEC source: 0001225208-17-003410 · doc4.xml · nonDerivative · entry 2 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,962.929 F2 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F3 · price: Represents the weighted average sales price for price increments ranging from $240.33 to $240.91. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
February 13, 2017 Filed Feb 14, 2017 15:20 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	450	$240.04	$108,018.50	Disclosure SEC source: 0001225208-17-003181 · doc4.xml · nonDerivative · entry 2 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,361.929 F2 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F3 · price: Represents the weighted average sales price for price increments ranging from $240.01 to $240.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
February 13, 2017 Filed Feb 15, 2017 16:58 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	667	$240.47	$160,393.49	Disclosure SEC source: 0001225208-17-003410 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,694.929 F1 · kind: Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document
February 10, 2017 Filed Feb 14, 2017 15:20 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	436	$239.93	$104,607.30	Disclosure SEC source: 0001225208-17-003181 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,811.929 F1 · kind: Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document
February 09, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	5,504	$239.66	$1,319,085.89	Disclosure SEC source: 0001225208-17-002838 · doc4.xml · nonDerivative · entry 6 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,247.929 F5 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F6 · price: Represents the weighted average sales price for price increments ranging from $239.39 to $239.82. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	4,116	$236.68	$974,174.88	Disclosure SEC source: 0001225208-17-002838 · doc4.xml · nonDerivative · entry 5 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,751.929 F4 · kind: Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	988	$164.84	$162,864.88	Disclosure SEC source: 0001225208-17-002838 · doc4.xml · nonDerivative · entry 4 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,867.929 F3 · kind: Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	2,308	$235.49	$543,510.92	Disclosure SEC source: 0001225208-17-002838 · doc4.xml · nonDerivative · entry 3 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,879.929 F3 · kind: Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	2,795	$0.00	$0.00	Disclosure SEC source: 0001225208-17-002838 · doc4.xml · nonDerivative · entry 2 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,571.929 F2 · price: Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	8,223	$0.00	$0.00	Disclosure SEC source: 0001225208-17-002838 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,776.929 F1 · price: Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document
January 11, 2017 Filed Jan 12, 2017 12:05 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	573	$235.00	$134,655.00	Disclosure SEC source: 0001225208-17-001027 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,553.929 F1 · kind: Sale is pursuant to a previously disclosed 10b5-1 plan. Read SEC document
December 14, 2016 Filed Dec 16, 2016 15:35 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantOption (Right to Buy) · Derivative	13,581	$0.00 Strike: $219.56	$0.00	Disclosure SEC source: 0001225208-16-043393 · doc4.xml · derivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,581 Underlying: Common Stock · 13,581 shares Expires 2026-12-14 F1 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F2 · derivative.exercise_date: Options vest in four equal annual installments beginning on December 14, 2017. Read SEC document
December 12, 2016 Filed Dec 14, 2016 12:11 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	304	$218.74	$66,495.44	Disclosure SEC source: 0001225208-16-043155 · doc4.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,126.929 F1 · kind: Shares withheld to pay taxes upon vesting of restricted stock units granted under the Company's 2012 Long Term Incentive Plan (As Amended and Restated). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.